Transplantation Industry Insights, Leading Players and Forecast Report, 2030

by Vijay K. Web Marketing

In 2021, the transplantation industry was worth around USD 13,605.9 million, and it is projected to advance at a 9.2% CAGR from 2022 to 2030, hitting USD 30,117.5 million by 2030, according to P&S Intelligence.

This growth can be credited to the growing occurrence of chronic illnesses, including myelodysplastic disorders, kidney failure, syndromes of the immune system, plasma cell disorders, and solid tumors.

Furthermore, the increasing knowledge regarding donating organs, coupled with technological enhancements, including robot-supported kidney transplants, and an overall enhancement in organ transportation success rates are contributing to the growth of the market.

In 2021, the North American transplantation market share was around 40%, the U.S. is dominating the regional market, as it has a huge patient base for organ transplantation, particularly for the pancreas, kidneys, intestines, liver, lungs, and heart.

Download sample pages of this report: https://www.psmarketresearch.com/market-analysis/transplantation-market/report-sample

Furthermore, R&D in the field has been offering a lift to the success rate of these events. For example, in February 2022, Carnegie Mellon University's Department of Biomedical Engineering and Mayo Clinic engaged in a 3-year research contract to bioengineer advanced methods to address the existing blockades in organ transplantation.

The APAC region, which is dominated by India, China, and Japan is the third-largest market, and it is projected to be the fastest-rising in the future, because of growth in medical tourism events and a surge in the occurrence of chronic diseases.

Hence, the growing occurrence of chronic illnesses, including myelodysplastic disorders, kidney failure, syndromes of the immune system, plasma cell disorders, and solid tumors, are the major factors boosting the transplantation industry.